[Form 4] Transcat Inc Insider Trading Activity

Rhea-AI Filing Summary

Transcat Inc (TRNS) director Oksana S. Dominach reported equity transactions on Form 4 reflecting restricted stock unit (RSU) activity and an outstanding stock option. On 09/11/2025, 704 RSUs were reported as acquired under transaction code M and converted into common stock at no cash price; 1,587 RSUs were reported as acquired on 09/10/2025 but vest on 09/10/2026 per the award terms. The filing also shows a fully vested stock option to purchase 10,000 shares at $26.27 expiring 10/22/2029. Following the reported transactions, Dominach beneficially owns 4,346 shares.

Positive

• Equity alignment: 704 RSUs vested and converted to common stock, increasing the director's direct ownership to 4,346 shares.
• Retention signal: A grant of 1,587 RSUs with a one-year vesting schedule aligns incentives for continued service.

Negative

• Potential dilution: The filing discloses a 10,000-share option exercisable at $26.27, which could dilute existing shareholders if exercised.
• Limited immediacy: The newly granted 1,587 RSUs do not vest until 09/10/2026, so they provide future, not current, ownership.

Insights

Corporate Governance Expert

TL;DR: Insider received vested equity and holds a sizable vested option, aligning pay with shareholder value but not clearly material.

The report documents customary equity compensation mechanics: vested RSUs converted to common stock and an existing vested option. Vesting schedules are standard and provide retention incentives. The conversion of RSUs at no cash price increases the director's direct ownership to 4,346 shares, while the 10,000-share option at $26.27 remains exercisable through 2029. There is no disclosure of disposals, sales, or exercise activity that would signal liquidity events or material shifts in ownership control.

Securities Analyst

TL;DR: Transactions reflect compensation vesting rather than active trading; impact on cap table appears limited based on reported amounts.

The Form 4 shows 1,587 RSUs granted (vesting 09/10/2026), 704 RSUs that vested on 09/11/2025, and a fully vested option for 10,000 shares exercisable at $26.27. The immediate effect is an increase in reported beneficial ownership to 4,346 shares. Absent information on total shares outstanding or subsequent exercises, the filing alone does not imply significant dilution or market impact. This is a routine disclosure of insider compensation and holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dominach Oksana S.

(Last) (First) (Middle)

C/O TRANSCAT, INC.

35 VANTAGE POINT DRIVE

(Street)

ROCHESTER NY 14624

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSCAT INC [ TRNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.50 par value	09/11/2025		M		704	A	$0(1)	4,346	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	09/10/2025		A		1,587		(2)	(2)	Common Stock, $.50 par value	1,587	$0	1,587	D
Restricted Stock Units	$0(1)	09/11/2025		M			704	(3)	(3)	Common Stock, $.50 par value	704	$0	0	D
Stock Option (Right to Buy)	$26.27							(4)	10/22/2029	Common Stock, $.50 par value	10,000		10,000	D

Explanation of Responses:

1. These restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

2. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 10, 2026.

3. These RSUs vested on September 11, 2025.

4. This option is fully vested as of the date of this report.

	/s/ Kristina L. Johnston, Attorney-in-Fact for Oksana S. Dominach	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did TRNS director Oksana Dominach report on Form 4?

The Form 4 reports conversion/vesting of 704 RSUs on 09/11/2025, a grant of 1,587 RSUs on 09/10/2025 (vesting 09/10/2026), and a fully vested stock option for 10,000 shares at $26.27 exercisable through 10/22/2029.

How many TRNS shares does Oksana Dominach beneficially own after the reported transactions?

Following the reported transactions, the filing shows Dominach beneficially owns 4,346 shares.

Do the reported RSUs require payment to convert to common stock?

No; the RSUs convert into common stock on a one-for-one basis at $0 per the filing.

When do the newly granted RSUs vest?

The 1,587 RSUs granted on 09/10/2025 vest on 09/10/2026 according to the award terms stated in the filing.

What is the exercise price and expiration of the reported option?

The stock option has an exercise price of $26.27 and an expiration date of 10/22/2029.